DOI: https://doi.org/10.22141/2224-0721.4.60.2014.76683

Effect of Probiotic Therapy on Clinical-Biochemical and Instrumental Parameters of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

G.P. Mykhalchyshyn, P.M. Bodnar, N.M. Kobyliak

Abstract


We examined 72 patients with type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). According to course of therapy all patients were divided into two groups. Patients of the main group (n = 45) received oral hypoglycemic agents and multiprobiotic symbiter within 30 days. To assess the functional state of the liver we studied protein, pigment, enzyme and lipid metabolism. All patients underwent ultrasound examination, including shear wave elastography. The efficacy of using multiprobiotic symbiter acidophilic concentrated in patients with DM type 2 and NAFLD has been proved. With increasing transaminases, hepatoprotective effect is a decrease of their levels in the blood, inflammatory and necrotic changes in the liver parenchyma. In patients with normal transaminases, hypolipidemic and antisteatogenic effects of multiprobiotic are present.


Keywords


diabetes mellitus type 2; nonalcoholic fatty liver disease; multyprobiotic symbiter

References


Боднар П.М., Динник О.Б., Михальчишин Г.П. та ін. Оцінка еластографії хвилі зсуву в діагностиці експериментальної неалкогольної жирової хвороби печінки // Журн. НАМН України. — 2011. — Т. 17, № 4. — С. 422-430.

Боднар П.М., Михальчишин Г.П., Кобиляк Н.М. Неалкогольна жирова хвороба печінки у хворих на цукровий діабет типу 2: патогенез, діагностика та лікування // Ендокринологія. — 2012. — Т. 17, № 1. — С. 94-101.

Интегральная роль симбиотической микрофлоры в физиологии человека / Янковский Д.С., Широбоков В.П., Дымент Г.С. — К.: Червона Рута-Турс, 2011. — 502 с.

Микрофлора и здоровье человека / Янковский Д.С., Дымент Г.С. — К.: Червона Рута-Турс, 2008. — 502 с.

Панькив В.И. Сахарный диабет 2-го типа и неалкогольная жировая болезнь печени. Эффекты метформина // Международный эндокринологический журнал. — 2013. — № 5(53). — С. 55-63.

Adachi Y., Moore L.E., Bradford B.U. et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol // Gastroenterology. — 1995. — 108. — Р. 218-224.

Backhed F., Ding H., Wang T. et al. The gut microbiota as an environmental factor that regulates fat storage // Proc. Natl. Acad. Sci. USA. — 2004. — 101. — Р. 15718-15723.

Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice // Proc. Natl. Acad. Sci. USA. — 2007. — 104. — Р. 979-984.

Carter B.A., Karpen S.J. Intestinal failure-associated liver disease: management and treatment strategies past, present and future // Semin. Liver Dis. — 2007. — 27. — Р. 251-258.

Cherbut C., Ferrier L., Roze C. et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat // Am. J. Physiol. — 1998. — 275. — Р. 1415-1422.

Chalasan N., Younossi Z., Lavine J. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association // Hepatology. — 2012. — Vol. 55, № 6. — P. 2005-2023.

Cope K., Risby T., Diehl A.M. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis // Gastroenterology. — 2000. — 119. — Р. 1340-1347.

Day C.P., James O.F. Steatohepatitis: a tale of two «hits»? // Gastroenterology. — 1998. — Vol. 114, № 4. — P. 842-845.

Day C.P. Pathogenesis of steatohepatitis // Best Pract. Res. Clin. Gastroenterol. — 2002. — Vol. 16, № 5. — P. 663-678.

Faggioni R. et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality // Am. J. Physiol. — 1999. — 276. — P. 136-142.

Fukumoto S., Tatewaki M., Yamada T. et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats // Am. J. Physiol. Regul. Integr. Comp. Physiol. — 2003. — 284. — P. 1269-1276.

Gustot T. et al. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver // Hepatology. — 2006. — 43. — P. 989-1000.

Samuel B.S., Shaito A., Motoike T. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 // Proc. Natl. Acad. Sci. USA. — 2008. — 105. — P. 16767-16772.

Solga S.F., Diehl A. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics // J. Hepatol. — 2003. — Vol. 38. — P. 681-687.

Vrieze А., Holleman F., Zoetendal E.G. et al. The environment within: how gut microbiota may influence metabolism and body composition // Diabetologia. — 2010. — Vol. 53, № 4. — P. 606-613.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта